Asian acquisitions of U.S. assets accelerate as Sun Pharma, Mitsubishi and SoftBank lead a structural shift in global capital flows
Asian acquisitions of U.S. assets accelerate as major deals by Sun Pharma, Mitsubishi and SoftBank signal a structural shift in global capital flows and strategy.
Asian acquisitions of U.S. assets are reshaping cross‑border investment patterns as a wave of high‑profile takeovers and multibillion‑dollar commitments from Indian and Japanese corporations mark a reversal in capital flows that for decades favored the United States. The trend, visible in deals completed since late 2025 and into 2026, has turned outbound Asian buyers into dominant acquirers of strategic American businesses. Market tallies and announced transactions show this is more than episodic buying; it reflects structural change in how firms secure technology, regulatory approvals and market access.
Major cross‑border deals driving the shift
Sun Pharma’s April 26 agreement to acquire the New Jersey‑based Organon for $11.75 billion in cash is among the highest‑profile examples of the reversal in capital flows. That transaction alone pushes an Indian firm into the top ranks of global producers of biosimilars and elevates its position in women’s health through a large U.S. distribution footprint.
Earlier in 2026, Mitsubishi completed a roughly $7.5 billion acquisition of U.S. natural gas assets from Ethon Energy, marking one of the largest Japanese investments in the American energy sector in recent memory. At the same time, SoftBank committed about $30 billion to an OpenAI infrastructure project named Stargate and paid $6.5 billion to acquire Ampere Computing, underlining a spree of technology and infrastructure investments by Asian investors in the United States.
Sumitomo’s $5.8 billion purchase of SCSK and other notable transactions round out a series of cross‑border moves that have transformed Asian companies from regional players into global buyers with strategic intent.
M&A volumes reveal a widening gap
Aggregate deal data for 2025 and early 2026 reinforce the narrative that capital flows are tilting. M&A value in the Asia‑Pacific region rose to approximately $946 billion in 2025, up from $687.7 billion in 2024. Japan reported about $385.9 billion of those transactions, while China’s deal value approached $399 billion — a year‑on‑year increase of roughly 46 percent.
India also saw a steep rise, with around $113 billion in merger and acquisition activity during 2025, representing annual growth near 42 percent. By comparison, the United States attracted roughly $385 billion in foreign direct investment in 2025, while the Americas collectively accounted for about 60 percent of global M&A value, underscoring the scale and speed of the ongoing adjustment.
Three structural drivers behind the reversal
First, changes in U.S. trade policy and tariff regimes altered the economics of exporting to the American market. Measures introduced in 2025 raised the cost of cross‑border supply chains and made onshore production or ownership of U.S. assets comparatively more attractive for foreign firms.
Second, Asian buyers are seeking strategic capabilities that are difficult to cultivate domestically, including U.S. Food and Drug Administration approvals, specialized manufacturing lines and established brand and distribution networks. Acquiring those assets directly accelerates market entry and reduces long lead times associated with building them from scratch.
Third, heightened geopolitical uncertainty has pushed firms to diversify asset locations and supply bases. Owning assets across multiple economic blocs is increasingly viewed as a hedge against political and trade disruptions, prompting acquisition strategies that prioritize resilience and control.
Strategic consequences for Asian firms
The most immediate consequence is a reallocation of valuation premia. Assets that once commanded higher prices in U.S. hands are now being paid for by Asian buyers, shifting the bargaining power in cross‑border deals. Companies that move early to secure overseas operations capture not only market access but also a premium in valuation.
This shift also forces a rethink in corporate capital structures. Firms that previously focused on domestic expansion are building balance sheets and financing programs capable of underwriting multibillion‑dollar takeovers, while augmenting governance and integration capabilities to manage large, cross‑border portfolios.
Policy and regulatory implications in host markets
The expansion of Asian acquisitions into sensitive sectors such as pharmaceuticals, energy and advanced computing is likely to prompt renewed scrutiny from U.S. and other host‑country regulators responsible for national security and critical infrastructure. Governments will need to balance openness to foreign investment with safeguards for strategic technologies and supply chains.
At the same time, Asian governments are under pressure to support outbound investment while ensuring domestic competitiveness. Policy choices around export controls, subsidies and diplomatic engagement will shape how smoothly these transactions move from announcement to closing.
What corporate founders and policymakers should prioritize
Corporate leaders in Asia must upgrade M&A capabilities, recruit executives with cross‑border integration experience and design financing structures that can support large strategic acquisitions at scale. Firms that treat international ownership as a near‑term strategic objective will be better positioned to compete globally.
Policymakers should consider frameworks that help domestic champions pursue overseas acquisitions while safeguarding national interests. That includes offering transaction support, enabling cross‑border financing arrangements and coordinating with partner jurisdictions on transparent review processes.
The rise of Asian acquisitions of U.S. assets reflects a deeper realignment in global capital flows driven by policy, strategic ambition and geopolitical risk. As more deals clear regulatory hurdles and Asian firms assume ownership of critical American assets, the path to global market leadership for many Asian corporates will increasingly run through cross‑border acquisition rather than purely organic expansion.
